Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

for
Prospective Observational Study, Gemcitabine, Docetaxel,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 21+

Code: NCT07662018

Recruiting

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

for
Cancer, Prostate Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07463833

Recruiting

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.

Sex: All

Age: 18+

Code: NCT02586389

Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency),
Location: New Haven CT, New York NY, Houston TX, Sacramento CA
Sponsor: Duke Street Bio Ltd

Sex: All

Age: 18+

Code: NCT06458712

Phase 1, Recruiting

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

for
Breast Cancer, Prostate Cancer, Colorectal Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07225309

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Decision Support Tool for Patients With Advanced Breast Cancer

for
Breast Cancer Metastatic, Advanced Breast Cancer,
Location: Flushing NY, New York NY, Brooklyn NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT07635147

Recruiting

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

for
Prostate Cancer, Refractory Cancer,
Location: Winston-Salem NC, Salisbury NC
Sponsor: Wake Forest University Health Sciences

Sex: Male

Age: 18+

Code: NCT04337580

Phase 2, Recruiting

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

for
Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07354100

Phase 1, Phase 2, Recruiting

Individuals on Hormone Therapy Breast Cancer Screening Pilot

for
Breast Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 30 - 70+

Code: NCT06383026

Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

for
Metastatic Breast Cancer, HER2-positive Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07053085

Phase 2, Recruiting

Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Richmond VA, Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18 - 70+

Code: NCT07474090

Recruiting

A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC)
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07513311

Recruiting

Evaluation of a Mobile App Program for Coping With Cancer

for
Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923501

Recruiting

A Study of a Side Effects and Resource Navigation Program for People With Cancer

for
Kidney Cancer, Bladder Cancer, Breast Cancer, Lung Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07646847

Recruiting

Human Observatory Study

for
Aging, Mortality, All-cause Mortality, Life Expectancy,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07646782

Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: The Bronx NY, New York NY, Wappingers Falls NY,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase 2, Recruiting

High-Resolution PET-CT Imaging for Surgical Margin Visualization

for
Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06915454

Recruiting

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

for
Breast Neoplasm
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18 - 70+

Code: NCT06294574

Recruiting

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05681026

Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial